ArticleScientific reports2025
A hybrid approach for enhancing pseudo-labeling in medical images through pseudo-label refinement.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Segmentation of medical images is critical for the evaluation, diagnosis, and treatment of various medical conditions. While deep learning-based approaches are the dominant methodology, they rely heavily on abundant labeled data and face significant challenges when data is limited. Semi-supervised learning methods mitigate this issue but there are still some challenges associated with them. Additionally, these approaches can be improved specifically for medical images considering their unique properties (e.g., smooth boundaries). In this work, we adapt and enhance the well-established pseudo-labeling approach specifically for medical image segmentation. Our exploration consists of modifying the network's loss function, pruning the pseudo-labels, and refining pseudo-labels by integrating traditional image processing methods with semi-supervised learning. This integration enables traditional segmentation techniques to complement deep semi-supervised methods, particularly in capturing fine edges where deep models often struggle. It also incorporates the smoothness of the edges in the segmentation and achieves a balance between deep learning and traditional methods through tunable parameters. Moreover, to address the problem of noisy or unreliable pseudo-labels, we utilize uncertainty-based pixel-level and image-level pruning of the pseudo-labels using a specific loss function, thereby improving the accuracy and robustness of the segmentation. We evaluated our approach on three different datasets from two imaging modalities (CT and MRI) and demonstrated its superior performance, highlighting its accuracy and robustness in the presence of limited labeled data. With only 15% of the labeled data, on the Sunnybrook Cardiac dataset, our approaches increased endocardium segmentation accuracy from 82.1% to 87.5%, and epicardium segmentation from 82.5% to 86.7%. On the COVID-19 CT lung and infection segmentation dataset, our approach improved left lung segmentation accuracy from 72.5% to 79.3%, and right lung segmentation from 75.8% to 81.6% when using only 15% of labeled data. On the Automated Cardiac Diagnostic Challenge dataset, with just 10% of labeled data, our approach increased endocardium segmentation from 91% to 93.7%, myocardium from 69.8% to 74.5%, and right ventricle from 76.7% to 82.1%. Our codes will be published in https://github.com/behnam-rahmati .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.